Article
CD38 and chronic lymphocytic leukemia: a decade later
16 Jul 2011
Abstract excerpt
This review highlights a decade of investigations into the role of CD38 in CLL. CD38 is accepted as a dependable marker of unfavorable prognosis and as an indicator of activation and proliferation of cells when tested. Leukemic clones with higher numbers of CD38(+) cells are more responsive to BCR signaling and are characterized by enhanced migration. In vitro activation through CD38 drives CLL proliferation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
